AWS brings AI agents into the lab to accelerate drug discovery
Amazon launched Amazon Bio Discovery at its AWS Life Sciences Symposium in mid-April. Memorial Sloan Kettering Cancer Center used the platform to design nearly 300,000 nanobody candidates against a pediatric cancer target in weeks and sent the top 100,000 to wet labs for synthesis and testing.